A decreased protein level in PDAC+ DM compared to PDAC was also detected via Western blots, which indicates a lower influence of S100A13 on tumor angiogenesis in these PDAC patients, rendering S100A13 an interesting marker for patients with PDAC+ DM. The gene discussed is S100A13; the disease is neoplasm.